• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经退行性疾病中的丘脑磁化率(χ)改变:定量磁化率图谱研究的系统评价和荟萃分析

Thalamic Magnetic Susceptibility (χ) Alterations in Neurodegenerative Diseases: A Systematic Review and Meta-Analysis of Quantitative Susceptibility Mapping Studies.

作者信息

Ghaderi Sadegh, Mohammadi Sana, Ahmadzadeh Amir Mahmoud, Darmiani Kimia, Arab Bafrani Melika, Jashirenezhad Nahid, Helfi Maryam, Alibabaei Sanaz, Azadi Sareh, Heidary Sahar, Fatehi Farzad

机构信息

Neuromuscular Research Center, Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

J Magn Reson Imaging. 2025 Jan 20. doi: 10.1002/jmri.29698.

DOI:10.1002/jmri.29698
PMID:39832811
Abstract

BACKGROUND

Quantitative Susceptibility Mapping (QSM) provides a non-invasive post-processing method to investigate alterations in magnetic susceptibility (χ), reflecting iron content within brain regions implicated in neurodegenerative diseases (NDDs).

PURPOSE

To investigate alterations in thalamic χ in patients with NDDs using QSM.

STUDY TYPE

Systematic review and meta-analysis.

POPULATION

A total of 696 patients with NDDs and 760 healthy controls (HCs) were included in 27 studies.

FIELD STRENGTH/SEQUENCE: Three-dimensional multi-echo gradient echo sequence for QSM at mostly 3 Tesla.

ASSESSMENT

Studies reporting QSM values in the thalamus of patients with NDDs were included. Following PRISMA 2020, we searched the four major databases including PubMed, Scopus, Web of Science, and Embase for peer-reviewed studies published until October 2024.

STATISTICAL TESTS

Meta-analysis was conducted using a random-effects model to calculate the standardized mean difference (SMD) between patients and HCs.

RESULTS

The pooled SMD indicated a significant increase in thalamic χ in NDDs compared to HCs (SMD = 0.42, 95% CI: 0.05-0.79; k = 27). Notably, amyotrophic lateral sclerosis patients showed a significant increase in thalamic χ (1.09, 95% CI: 0.65-1.53, k = 2) compared to HCs. Subgroup analyses revealed significant χ alterations in younger patients (mean age ≤ 62 years; 0.56, 95% CI: 0.10-1.02, k = 11) and studies using greater coil channels (coil channels > 16; 0.64, 95% CI: 0.28-1.00, k = 9). Publication bias was not detected and quality assessment indicated that studies with a lower risk of bias presented more reliable findings (0.75, 95% CI: 0.32-1.18, k = 9). Disease type was the primary driver of heterogeneity, while other factors, such as coil type and geographic location, also contributed to variability.

DATA CONCLUSION

Our findings support the potential of QSM for investigating thalamic involvement in NDDs. Future research should focus on disease-specific patterns, thalamic-specific nucleus analysis, and temporal evolution.

PLAIN LANGUAGE SUMMARY

Our research investigated changes in iron levels within the thalamus, a brain region crucial for motor and cognitive functions, in patients with various neurodegenerative diseases (NDDs). The study utilized a specific magnetic resonance imaging technique called Quantitative Susceptibility Mapping (QSM) to measure iron content. It identified a significant increase in thalamic iron levels in NDD patients compared to healthy individuals. This increase was particularly prominent in patients with Amyotrophic Lateral Sclerosis, younger individuals, and studies employing advanced imaging equipment.

LEVEL OF EVIDENCE

2 TECHNICAL EFFICACY: Stage 2.

摘要

背景

定量磁化率图谱(QSM)提供了一种非侵入性的后处理方法,用于研究磁化率(χ)的变化,反映神经退行性疾病(NDDs)相关脑区内的铁含量。

目的

使用QSM研究NDDs患者丘脑χ的变化。

研究类型

系统评价和荟萃分析。

研究对象

27项研究共纳入696例NDDs患者和760例健康对照(HCs)。

场强/序列:主要在3特斯拉下用于QSM的三维多回波梯度回波序列。

评估

纳入报告NDDs患者丘脑QSM值的研究。遵循PRISMA 2020,我们在包括PubMed、Scopus、Web of Science和Embase在内的四个主要数据库中检索截至2024年10月发表的同行评审研究。

统计检验

采用随机效应模型进行荟萃分析,以计算患者与HCs之间的标准化平均差(SMD)。

结果

汇总的SMD表明,与HCs相比,NDDs患者丘脑χ显著增加(SMD = 0.42,95%CI:0.05 - 0.79;k = 27)。值得注意的是,与HCs相比,肌萎缩侧索硬化患者丘脑χ显著增加(1.09,95%CI:0.65 - 1.53,k = 2)。亚组分析显示,年轻患者(平均年龄≤62岁;0.56,95%CI:0.10 - 1.02,k = 11)和使用更多线圈通道的研究(线圈通道>16;0.64,95%CI:0.28 - 1.00,k = 9)中χ有显著变化。未检测到发表偏倚,质量评估表明偏倚风险较低的研究呈现出更可靠的结果(0.75,95%CI:0.32 - 1.18,k = 9)。疾病类型是异质性的主要驱动因素,而其他因素,如线圈类型和地理位置,也导致了变异性。

数据结论

我们的研究结果支持QSM在研究丘脑参与NDDs方面的潜力。未来的研究应关注疾病特异性模式、丘脑特异性核分析和时间演变。

通俗易懂的总结

我们的研究调查了各种神经退行性疾病(NDDs)患者中,丘脑(对运动和认知功能至关重要的脑区)内铁水平的变化。该研究利用一种名为定量磁化率图谱(QSM)的特定磁共振成像技术来测量铁含量。研究发现,与健康个体相比,NDDs患者丘脑铁水平显著增加。这种增加在肌萎缩侧索硬化患者、年轻个体以及采用先进成像设备的研究中尤为明显。

证据水平

2 技术效能:2级

相似文献

1
Thalamic Magnetic Susceptibility (χ) Alterations in Neurodegenerative Diseases: A Systematic Review and Meta-Analysis of Quantitative Susceptibility Mapping Studies.神经退行性疾病中的丘脑磁化率(χ)改变:定量磁化率图谱研究的系统评价和荟萃分析
J Magn Reson Imaging. 2025 Jan 20. doi: 10.1002/jmri.29698.
2
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
5
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
6
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
7
Couple therapy for depression.针对抑郁症的夫妻治疗。
Cochrane Database Syst Rev. 2018 Jun 8;6(6):CD004188. doi: 10.1002/14651858.CD004188.pub3.
8
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的计算机和移动技术干预措施。
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.
9
Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis.复杂创伤性事件后创伤后应激障碍及共患精神健康问题的心理和药理学干预措施:系统评价和成分网络荟萃分析。
PLoS Med. 2020 Aug 19;17(8):e1003262. doi: 10.1371/journal.pmed.1003262. eCollection 2020 Aug.
10
Non-invasive brain stimulation techniques for chronic pain.用于慢性疼痛的非侵入性脑刺激技术
Cochrane Database Syst Rev. 2018 Apr 13;4(4):CD008208. doi: 10.1002/14651858.CD008208.pub5.